AMD3100 sensitizes acute lymphoblastic leukemia cells to chemotherapy in vivo

被引：19
|
作者：
Yu, M. [1 ,2 ]
Gang, E. J. [3 ,4 ]
Parameswaran, R. [1 ,2 ]
Stoddart, S. [1 ,2 ]
Fei, F. [1 ,2 ]
Schmidhuber, S. [1 ,2 ]
Park, E. [3 ,4 ]
Hsieh, Y. T. [3 ,4 ]
Yang, A. S. [5 ]
Groffen, J. [1 ,2 ,3 ,4 ]
Heisterkamp, N. [1 ,2 ,3 ,4 ]
Kim, Y. M. [3 ,4 ]
机构：
[1] Childrens Hosp Los Angeles, Sect Mol Carcinogenesis, Div Hematol Oncol, Los Angeles, CA 90027 USA
[2] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA
[3] Univ So Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA 90033 USA
[4] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA
[5] Univ So Calif, Keck Sch Med, Jane Anne Nohl Div Hematol, Ctr Blood Dis,Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA
来源：
BLOOD CANCER JOURNAL | 2011年 / 1卷
关键词：
CXCR4; ANTAGONIST; MICROENVIRONMENT; MOBILIZATION; RESISTANCE; INHIBITORS; AML;
D O I：
10.1038/bcj.2011.13
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：e14 / e14
页数：3
相关论文
共 50 条
  • [31] Autophagy Inhibition Sensitizes Acute Lymphoblastic Leukemia Cells to L-Asparaginase
    Takahashi, Hiroyoshi
    Inoue, Jun
    Sakaguchi, Kimiyoshi
    Takagi, Masatoshi
    Mizutani, Shuki
    Inazawa, Johji
    BLOOD, 2015, 126 (23)
  • [32] CXCR4 blockade with AMD3100 enhances Taxol chemotherapy to limit ovarian cancer cell growth
    Reeves, Patrick M.
    Abbaslou, Mojgan A.
    Kools, Farah R. W.
    Poznansky, Mark C.
    ANTI-CANCER DRUGS, 2017, 28 (09) : 935 - 942
  • [33] The CXCR4 Antagonist AMD3100 Impairs Survival of AML Cells and Induces Their Differentiation
    Tavor, Sigal
    Eisenbach, Manny
    Jacob-Hirsch, Jasmine
    Golan, Tammar
    Petit, Isabelle
    Ben-Zion, Katz
    Kay, Sigi
    Baron, Shoshana
    Amariglio, Ninette
    Deutsch, Varda
    Naparstek, Elizabeth
    Rechavi, Gideon
    BLOOD, 2008, 112 (11) : 573 - 573
  • [34] Effectiveness of AMD3100 in treatment of leukemia and solid tumors: From original discovery to use in current clinical practice
    Liu T.
    Li X.
    You S.
    Bhuyan S.S.
    Dong L.
    Experimental Hematology & Oncology, 5 (1)
  • [35] G-CSF and AMD3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanism
    Capoccia, Benjamin J.
    Shepherd, Rebecca M.
    Link, Daniel C.
    BLOOD, 2006, 108 (07) : 2438 - 2445
  • [36] In vivo validation of 68Ga-labeled AMD3100 conjugates for PET imaging of CXCR4
    Renard, Isaline
    Domarkas, Juozas
    Poty, Sophie
    Burke, Benjamin P.
    Roberts, David P.
    Goze, Christine
    Denat, Franck
    Cawthorne, Christopher J.
    Archibald, Stephen J.
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 120
  • [37] Acute lymphoblastic leukemia cells that survive combination chemotherapy in vivo remain sensitive to allogeneic immune effects
    Jansson, Johan
    Hsu, Yu-Chiao
    Kuzin, Igor I.
    Campbell, Andrew
    Mullen, Craig A.
    LEUKEMIA RESEARCH, 2011, 35 (06) : 800 - 807
  • [38] Successful mobilization of peripheral blood stem cells (PBSCs) with AMD3100 in patients failing to collect with hematopcietic growth factors (HGF) and/or chemotherapy.
    Fassas, A
    Fox, M
    Calandra, G
    Tricot, G
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 593S - 593S
  • [39] Failure to Mobilize Peripheral Blood Hematopoietic Stem Cells Upon Readministration of AMD3100 in Nonhuman Primates
    Samuelson, Clare
    Humbert, Olivier
    Radtke, Stefan
    Perez, Anai
    Cui, Margaret
    Kiem, Hans-Peter
    MOLECULAR THERAPY, 2019, 27 (04) : 66 - 67
  • [40] AMD3100 DISRUPTS THE CROSS-TALK BETWEEN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS AND THEIR MICROENVIRONMENT: PRECLINICAL EVIDENCE FOR ITS COMBINATION WITH CLL TREATMENTS
    Stamatopoulos, B.
    Le Roy, C.
    Meuleman, N.
    De Bruyn, C.
    Pieters, K.
    Mineur, P.
    Ledoux, D.
    Varin-Blank, N.
    Cymbalista, F.
    Bron, D.
    Lagneaux, L.
    ANNALS OF ONCOLOGY, 2011, 22 : 84 - 85
12345